Semih Ullah Tareen

USPTO Granted Patents = 9 (Patent Applications = 7)

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 5 (Patent Applications = 8)

Average Co-Inventor Count = 2.2

ph-index = 5

Forward Citations = 30(Granted Patents)

Company Filing History:

5 out of 66

Juno Therapeutics Gmbh

Memorial Sloan Kettering Cancer Center

where one patent can have more than one assignee

Years Active: 2012-2025

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12428486 - Chimeric antigen receptors specific for B-cell maturation antigen and encoding polynucleotides (2025-09-30),

2. 12129477 - Methods, kits, agents and apparatuses for transduction (2024-10-29),

3. 11248238 - Methods, kits, agents and apparatuses for transduction (2022-02-15),

4. 11066475 - Chimeric antigen receptors specific for B-cell maturation antigen and encoding polynucleotides (2021-07-20),

5. 10993999 - Materials and methods for producing improved lentiviral vector particles (2021-05-04),

6. 10391157 - Materials and methods for producing improved lentiviral vector particles (2019-08-27),

7. 10363269 - Modified hepatitis post-transcriptional regulatory elements (2019-07-30),

8. 9713635 - Materials and methods for producing improved lentiviral vector particles (2017-07-25),

9. 8323662 - Methods useful for generating highly mannosylated pseudotyped lentiviral vector particles comprising a Vpx protein (2012-12-04),

Title: **Innovative Contributions of Semih Ullah Tareen in Cellular Transduction**

Introduction

Semih Ullah Tareen is a prominent inventor based in Seattle, Washington, recognized for his significant contributions to the field of cellular biology and transduction methods. With a remarkable portfolio of eight patents, Tareen's innovative work has propelled advancements in the understanding and manipulation of cellular processes, particularly in lymphocyte populations.

Latest Patents

Among Semih Ullah Tareen's recent inventions is a groundbreaking patent focusing on methods, kits, agents, and apparatuses for transduction. This invention details techniques for transducing various cells within a composition, such as a population of lymphocytes containing viral particles. Key aspects of this patent include the use of agents that bind to molecules on the surface of cells, enhancing the efficacy of transduction. Additionally, the invention discusses multimerization reagents that allow agents to be multimerized through reversible bonding, thus facilitating the expansion or stimulation of cell populations. This innovative approach allows for the subsequent removal of agents by disrupting the reversible bond, showcasing a sophisticated method for cellular manipulation.

Career Highlights

Throughout his career, Semih Ullah Tareen has made notable strides in the biotechnology industry. He has been instrumental in the development of cellular therapies and has worked with esteemed companies such as Juno Therapeutics and Immune Design Corporation. His work has been pivotal in translating complex scientific concepts into applicable therapeutic solutions.

Collaborations

Tareen's journey has included collaborations with skilled professionals in the field. Notably, he has worked alongside notable peers such as Christopher James Nicolai and Keenan Bashour. These collaborations have further enriched his research and development efforts, leading to impactful innovations in cellular biology.

Conclusion

In summary, Semih Ullah Tareen exemplifies the spirit of innovation within the realm of cellular transduction. His eight patents and collaborative efforts highlight his dedication to advancing scientific knowledge and developing practical applications that can benefit various therapeutic areas. As he continues to shape the future of cellular manipulation, Tareen remains a key figure in the landscape of modern biotechnological inventions.

This text is generated by artificial intelligence and may not be accurate.